ADHD medications and cardiovascular adverse events in children and adolescents: cross-national comparison of risk communication in drug labeling

摘要

Purpose Regulators approve written medical information for healthcare professionals and consumers, but the consistency of these sources has not been studied. We investigated the consistency of information regarding four cardiovascular risks of attention-deficit/hyperactivity disorder (ADHD) medications approved in four countries.